CEO: | Stephen O'Hara |
Finance Director: | Graham Myers |
Non-Executive Chairman: | Neil Davidson |
Research and Development Director: | Sofia Kolyda |
Non-Executive Dir: | Sean Christie |
Address: | 145-147 St John Street, London, EC1V 4PY |
Phone: | + 44 (0) 203 178 5618 |
Website: | http://www.optibiotix.com |
Sector: | Pharma and Biotech(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00BP0RTP38 |
Currency | UK Pounds |
Share Price | 12.25p |
Change Today | -0.75p |
% Change | -5.77 % |
52 Week High | 33.00p |
52 Week Low | 10.25p |
Volume | 104,032 |
Shares Issued | 97.94m |
Market Cap | £12.00m |
Beta | 0.59 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:14 | 3,222 @ 12.41p |
16:05 | 10,000 @ 12.12p |
16:01 | 15,009 @ 12.16p |
15:55 | 4,000 @ 12.50p |
13:58 | 20,000 @ 12.50p |
CEO | Stephen O'Hara |
Finance Director | Graham Myers |
You are here: research